Compare HELP & FFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HELP | FFA |
|---|---|---|
| Founded | N/A | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 375.7M | 429.4M |
| IPO Year | N/A | N/A |
| Metric | HELP | FFA |
|---|---|---|
| Price | $7.76 | $22.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 847.6K | 26.1K |
| Earning Date | 02-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 6.72% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.81 | $15.84 |
| 52 Week High | $10.72 | $19.30 |
| Indicator | HELP | FFA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 56.27 |
| Support Level | N/A | $21.92 |
| Resistance Level | N/A | $22.13 |
| Average True Range (ATR) | 0.00 | 0.16 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 0.00 | 65.57 |
First Trust Enhanced Equity Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide high level of current income and gains and, to a lesser extent, capital appreciation. The Fund pursues its investment objective by investing in a diversified portfolio of equity securities.